CMS Open Payments · Program Year 2024
Clinical Laserthermia Systems Americas Inc.
Clinical Laserthermia Systems Americas Inc. reported $1,731.39 across General Payments, Research, and Ownership to 40 physicians and teaching hospitals across 40 transactions.
- $1.7K Below-median payer
- All-tracks total
- 40 Below-median volume
- Transactions
- 40 Below-median reach
- Recipients
- −$3.4K
- General Payments vs PY2023
Clinical Laserthermia Systems Americas Inc. reported $1,731.39 across all CMS Open Payments tracks (General + Research + Ownership) to 40 physicians and teaching hospitals in Program Year 2024 - ranking #1809 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,731.39, averaging $43.28 per recipient.
Clinical Laserthermia Systems Americas Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
13/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer clinical-laserthermia-systems-americas-inc Clinical Laserthermia Systems Americas Inc.
$1.7K · #1809/1,925 · 0.0% industry · PY2024
- TOT $1.7K
- RANK #1809
- SHARE 0.0%
- TXN 40
- RCP 40
- CAT 2
- GEN $1.7K
- ΔGEN −$3.4K
- TOP1 29.9%
- PY 2024
Volume peers
Nearest volume peer: Strategic Dentistry LLC ($1.7K)
Clinical Laserthermia Systems Americas Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Clinical Laserthermia Systems Americas Inc.'s CMS-reported General Payments decreased by $3.4K (−66.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CLINICAL LASERTHERMIA SYSTEMS AMERICAS INC.PY2023: CLINICAL LASERTHERMIA SYSTEMS AMERICAS INC.PY2024: Clinical Laserthermia Systems Americas Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $5,096.75
- PY2024
- $1,731.39
What the Data Shows for Clinical Laserthermia Systems Americas Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Clinical Laserthermia Systems Americas Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
37 transactions worth $1.2K make "Food and Beverage" the top general-payment category in the 2-category breakdown below, 70.8% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Clinical Laserthermia Systems Americas Inc. made 2 types of general payments. "Food and Beverage" is the largest category at $1.2K, 70.8% of General Payments.
How Clinical Laserthermia Systems Americas Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $1.2K | 37 | 70.8% |
| Travel and Lodging | $506.24 | 3 | 29.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,145.79 (66.2%) of $1,731.39 in this company's General Payments records across 13 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Clinical Laserthermia Systems Americas Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Amit Gupta
$517.61 across 4 reported transactions
- 2
Sijo Joseph Parekattil
$189.84 across 12 reported transactions
- 3
Laura R Brumbaugh
$167.78 across 11 reported transactions
- 4
Joseph Anthony Altamirando
$135.28 across 1 reported transactions
- 5
Ali Kasraeian
$135.28 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Clinical Laserthermia Systems Americas Inc. ranks #1809 of 1,925 by total payments (bottom 6% by spend) but is notably more concentrated than that alone would suggest -- #894 of 1,838 by HHI (top 49% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Total Joint Orthopedics, Inc. : $245.5K total payments, HHI 1433
- Great Lakes Medical Services, LLC : $5.8K total payments, HHI 1429
- Virtual Incision Corporation : $447.4K total payments, HHI 1423
- Aadi Bioscience, Inc. : $255.4K total payments, HHI 1423
- Empire Medical, Inc : $4.0K total payments, HHI 1422
- Cipla USA Inc. : $2.2M total payments, HHI 1419
- Clinical Laserthermia Systems Americas Inc. (this company) : $1.7K total payments, HHI 1414
- ABK Biomedical USA, Inc. : $6.6K total payments, HHI 1409
- Cadwell Industries, INC : $39.8K total payments, HHI 1407
- Carestream Dental, LLC : $175.9K total payments, HHI 1402
- Daxor Corporation : $270.6K total payments, HHI 1400
- US Retina LLC : $355.0K total payments, HHI 1391
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Clinical Laserthermia Systems Americas Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Clinical Laserthermia Systems Americas Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Clinical Laserthermia Systems Americas Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Metacel Pharmaceuticals LLC
Vital Orthopedics Llc
CroiValve inc
Arthrosurface Incorporated
Techfit Digital Surgery Inc
Put this to use
Clinical Laserthermia Systems Americas Inc. ranks #1809 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Clinical Laserthermia Systems Americas Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.